e-SPACE Cardio-Renal-Metabolic 2022: On-demand

Published: 11 April 2022

  • Views:

    Views Icon 12307
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 27 | Session 6 of 6
    Panel discussion
    Hiddo Lambers Heerspink
    Up Next
  • episode_image
    1m 29s
    Part 4 | Session 1 Introduction Vijay Chopra, Marco Metra
  • episode_image
    1m 9s
    Part 6 | Session 1 Introduction Andrew JS Coats, Alice Cheng
  • episode_image
    1m
    Part 11 | Session 1 Introduction Mustafa Arici, Pardeep Jhund
  • episode_image
    1m 15s
    Part 13 | Session 1 Introduction Fausto J Pinto, Clara Saldarriaga, Stefan Anker
  • episode_image
    8m 55s
    Part 13 | Session 3 6.2: Preserved HF Fausto J Pinto, Clara Saldarriaga, Stefan Anker
  • episode_image
    24m 16s
    Part 13 | Session 6 Panel discussion Fausto J Pinto, Clara Saldarriaga, Stefan Anker
  • episode_image
    31m 48s
    Part 16 | Session 5 Panel discussion Stefan Anker, Stephan Von Haehling
  • episode_image
    2m 7s
    Part 22 | Session 1 Introduction Piotr Ponikowski, Muthiah Vaduganathan
  • episode_image
    24m 22s
    Part 22 | Session 6 Panel discussion Piotr Ponikowski, Muthiah Vaduganathan
  • episode_image
    50s
    Part 24 | Session 1 Introduction Stefan Anker, Linda Mellbin
  • episode_image
    2m 39s
    Part 27 | Session 1 Introduction Hiddo Lambers Heerspink
Average (ratings)
No ratings
Your rating

Overview

e-SPACE CARDIO-RENAL-METABOLIC 2022, held on 4-6 March 2022, was the second edition of the global online conference on cardio renal metabolic diseases.

 

The organisers, under the direction of a world-renowned scientific committee, brought together leading experts in cardiology, nephrology, and diabetology to share clinical practice strategies in treating the inter-related diseases now affecting hundreds of millions people worldwide.

 

This on-demand version of the event comprises:

 

  • Presentations and discussions with leading experts
  • Evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity
  • Insight to SLGT2i, GLP-1RA and other emerging therapies
  • 'Meet the Expert' sessions

 

e-SPACE Cardio-Renal-Metabolic 2022 was supported by the following companies:

More from this programme

Part 1

Meet the Expert: IgA nephropathy: current optimal management

Part 3

Industry Session: Iron deficiency in heart failure and kidney disease: interdisciplinary crosstalk

Part 5

Meet the Experts: NAFLD/NASH as a metabolic disease: improving patients outcomes

Part 7

Meet the Experts: The meaning of Hemoglobin A1C for the nephrologist and the cardiologist

Part 12

Meet the Experts: CV, mortality & kidney outcomes with GLP-1 AR in patients with T2DM

Part 14

Meet the Experts: The HF Diabetic patient with CKD: optimizing care for a high-risk group

Part 17

Meet the Expert: HIF PHI: What do we know and don't know in 2022

Part 19

Industry Session: SGLT2 inhibition in the comorbid CKD patient

Satellite Symposium supported by an unrestricted educational grant from AstraZeneca

Part 21

Meet the Expert: SGLT2 inhibitors in heart failure: Improving outcomes across the spectrum of the disease

Part 23

Meet the Expert: The meaning of eGFR for the cardiologists and diabetologist

Part 25

Meet the Experts: Personalized care of patients with heart failure: hyperkalemia as a barrier to optimal medical therapy

Part 26

Meet the Expert: SGLT2, the statin of the 21st century

Part 28

Meet the Experts: Reducing the risk of cardiovascular events for patients with CKD and T2DM: new treatment options

Part 31

Meet the Expert: Management of worsening HF

Part 32

Session 16: Harmonising the gluco-and cardio-centric management of diabetes

Faculty Biographies

Hiddo Heerspink

Hiddo Heerspink

Clinical Pharmacologist

Prof Hiddo Heerspink’s is a Clinical Pharmacologist at the Department of Clinical Pharmacy and Pharmacology at the University Medical Center Groningen, the Netherlands. he also serves as a Visiting Professor at the University of New South Wales in Sydney, Australia. Prof Heerspink's research interests include treatment strategies and therapeutic approaches for the treatment of renal and cardiovascular disease in patients with diabetes.

View full profile